Diederen Kay, Gerritsma Jorn J, Koot Bart G P, Tabbers Merit M, Benninga Marc A, Kindermann Angelika
Department of Pediatric Gastroenterology, Emma Children's Hospital/Academic Medical Center, Amsterdam, The Netherlands.
J Pediatr Gastroenterol Nutr. 2018 Mar;66(3):410-416. doi: 10.1097/MPG.0000000000001712.
The degree to which children and adolescents with inflammatory bowel disease (IBD) complete clinical disease activity indices in accordance with their physician is indefinite. Therefore, we investigated the agreement between patient- and physician-based clinical indices in children and adolescents with a previous diagnosis of IBD.
In this cross-sectional study, IBD patients (8-18 years) were included prospectively. Patients completed a patient-based short Pediatric Crohn's Disease Activity Index (shPCDAI) for Crohn disease or the Pediatric Ulcerative Colitis Activity Index (PUCAI) for ulcerative or indeterminate colitis. Physicians completed the original physician-based shPCDAI or PUCAI. Agreement was calculated with linear weighted kappa.
In total, 154 pairs of clinical indices were collected: 89 pairs of shPCDAI's (median age at assessment 15.6 years, 61% men) and 55 pairs of PUCAI's (median age at assessment 14.0 years, 44% men). The shPCDAI disease activity category only fairly agreed between patient- and physician-based indices (kappa: 0.40 [95% confidence interval 0.24-0.55], P < 0.001), with perfect agreement in 58% of pairs. In the majority of disagreement (81%), patients scored in a higher shPCDAI disease activity category. The PUCAI disease activity category substantially agreed between patient- and physician-based indices (kappa: 0.64 [95% confidence interval 0.45-0.83], P < 0.001), with perfect agreement in 78% of pairs. In the majority of disagreement (75%), patients scored in a higher PUCAI disease activity category.
Patient- and physician-based shPCDAI and PUCAI do not always agree, particularly the shPCDAI, and therefore, should not be interpreted equivalently in management and research on children and adolescents with IBD.
患有炎症性肠病(IBD)的儿童和青少年按照医生要求完成临床疾病活动指数的程度尚不确定。因此,我们调查了先前诊断为IBD的儿童和青少年中基于患者和基于医生的临床指数之间的一致性。
在这项横断面研究中,前瞻性纳入了8至18岁的IBD患者。患者完成了基于患者的用于克罗恩病的简短儿童克罗恩病活动指数(shPCDAI)或用于溃疡性结肠炎或不确定性结肠炎的儿童溃疡性结肠炎活动指数(PUCAI)。医生完成了原始的基于医生的shPCDAI或PUCAI。使用线性加权kappa计算一致性。
总共收集了154对临床指数:89对shPCDAI(评估时的中位年龄为15.6岁,男性占61%)和55对PUCAI(评估时的中位年龄为14.0岁,男性占44%)。基于患者和基于医生的指数之间,shPCDAI疾病活动类别仅具有中等程度的一致性(kappa:0.40 [95%置信区间0.24 - 0.55],P<0.001),58%的配对完全一致。在大多数不一致的情况(81%)中,患者的shPCDAI疾病活动类别得分更高。基于患者和基于医生的指数之间,PUCAI疾病活动类别具有实质性的一致性(kappa:0.64 [95%置信区间0.45 - 0.83],P<0.001),78%的配对完全一致。在大多数不一致的情况(75%)中,患者的PUCAI疾病活动类别得分更高。
基于患者和基于医生的shPCDAI和PUCAI并不总是一致,尤其是shPCDAI,因此,在IBD儿童和青少年的管理和研究中不应同等看待。